Marcella K. Ruddy - 06 Feb 2025 Form 4 Insider Report for Sionna Therapeutics, Inc. (SION)

Reporting relationship: Director
Issuer ticker: SION
Reported as of: 06 Feb 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Feb 2025, 16:05:17 UTC
Prior SEC filing: 06 Feb 2025
Next SEC filing: 12 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Jennifer Fitzpatrick, Attorney-in-Fact

Key filing fact

Marcella K. Ruddy filed Form 4 for Sionna Therapeutics, Inc. (SION) on 10 Feb 2025.

Key facts

This page summarizes Marcella K. Ruddy's Form 4 filing for Sionna Therapeutics, Inc. (SION).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Feb 2025, 16:05.

Change

Previous filing in this sequence was filed on 06 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SION transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +39,919
Change %
Price: $0.000000
Shares after: 39,919
Date: 06 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 39,919
Exercise price: $18.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this option vest in three equal annual installments following February 6, 2025, subject to the Reporting Person's continued service on each such vesting date.